Literature DB >> 28601553

Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.

Ami Mankodi1, Noura Azzabou2, Thomas Bulea3, Harmen Reyngoudt2, Hirity Shimellis4, Yupeng Ren5, Eunhee Kim6, Kenneth H Fischbeck4, Pierre G Carlier2.   

Abstract

The purpose of this study was to examine exercise effects on muscle water T2 in patients with Duchenne muscular dystrophy (DMD). In 12 DMD subjects and 19 controls, lower leg muscle fat (%) was measured by Dixon and muscle water T2 and R2 (1/T2) by the tri-exponential model. Muscle water R2 was measured again at 3 hours after an ankle dorsiflexion exercise. The muscle fat fraction was higher in DMD participants than in controls (p < .001) except in the tibialis posterior muscle. Muscle water T2 was measured independent of the degree of fatty degeneration in DMD muscle. At baseline, muscle water T2 was higher in all but the extensor digitorum longus muscles of DMD participants than controls (p < .001). DMD participants had a lower muscle torque (p < .001) and exerted less power (p < .01) during exercise than controls. Nevertheless, muscle water R2 decreased (T2 increased) after exercise from baseline in DMD subjects and controls with greater changes in the target muscles of the exercise than in ankle plantarflexor muscles. Skeletal muscle water T2 is a sensitive biomarker of the disease status in DMD and of the exercise response in DMD patients and controls. Published by Elsevier B.V.

Entities:  

Keywords:  Duchenne muscular dystrophy; Exercise; Fat fraction; Magnetic resonance imaging; Skeletal muscle; Water T(2)

Mesh:

Substances:

Year:  2017        PMID: 28601553      PMCID: PMC5538585          DOI: 10.1016/j.nmd.2017.04.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  57 in total

Review 1.  Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex.

Authors:  Basil J Petrof
Journal:  Am J Phys Med Rehabil       Date:  2002-11       Impact factor: 2.159

2.  Dynamic ASL and T2-weighted MRI in exercising calf muscle at 7 T: a feasibility study.

Authors:  Kiril Schewzow; Georg Bernd Fiedler; Martin Meyerspeer; Sigrun Goluch; Elmar Laistler; Michael Wolzt; Ewald Moser; Albrecht Ingo Schmid
Journal:  Magn Reson Med       Date:  2014-04-17       Impact factor: 4.668

3.  Plasma creatine kinase changes after eccentric and concentric contractions.

Authors:  D J Newham; D A Jones; R H Edwards
Journal:  Muscle Nerve       Date:  1986-01       Impact factor: 3.217

4.  Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.

Authors:  Roy W R Dudley; Gawiyou Danialou; Karuthapillai Govindaraju; Larry Lands; David E Eidelman; Basil J Petrof
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 5.  Molecular pathophysiology and targeted therapeutics for muscular dystrophy.

Authors:  E P Hoffman; D Dressman
Journal:  Trends Pharmacol Sci       Date:  2001-09       Impact factor: 14.819

Review 6.  The muscular dystrophies.

Authors:  Alan E H Emery
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

7.  Body segment mass, radius and radius of gyration proportions of children.

Authors:  R K Jensen
Journal:  J Biomech       Date:  1986       Impact factor: 2.712

8.  Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes.

Authors:  Thomas Loughran; David M Higgins; Michelle McCallum; Anna Coombs; Volker Straub; Kieren G Hollingsworth
Journal:  Radiology       Date:  2015-01-07       Impact factor: 11.105

9.  Dystrophin quantification: Biological and translational research implications.

Authors:  Karen Anthony; Virginia Arechavala-Gomeza; Laura E Taylor; Adeline Vulin; Yuuki Kaminoh; Silvia Torelli; Lucy Feng; Narinder Janghra; Gisèle Bonne; Maud Beuvin; Rita Barresi; Matt Henderson; Steven Laval; Afrodite Lourbakos; Giles Campion; Volker Straub; Thomas Voit; Caroline A Sewry; Jennifer E Morgan; Kevin M Flanigan; Francesco Muntoni
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

10.  Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Authors:  Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more
  7 in total

Review 1.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

2.  Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and 31P nuclear magnetic resonance spectroscopy.

Authors:  Harmen Reyngoudt; Benjamin Marty; Ericky Caldas de Almeida Araújo; Pierre-Yves Baudin; Julien Le Louër; Jean-Marc Boisserie; Anthony Béhin; Laurent Servais; Teresa Gidaro; Pierre G Carlier
Journal:  Quant Imaging Med Surg       Date:  2020-07

3.  Quantitative water T2 relaxometry in the early detection of neuromuscular diseases: a retrospective biopsy-controlled analysis.

Authors:  Noah Locher; Benedikt Wagner; Fabian Balsiger; Olivier Scheidegger
Journal:  Eur Radiol       Date:  2022-05-21       Impact factor: 5.315

4.  The Donnan-dominated resting state of skeletal muscle fibers contributes to resilience and longevity in dystrophic fibers.

Authors:  Catherine E Morris; Joshua J Wheeler; Béla Joos
Journal:  J Gen Physiol       Date:  2021-11-03       Impact factor: 4.000

5.  T2 relaxation-time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms.

Authors:  Kevin R Keene; Jan-Willem M Beenakker; Melissa T Hooijmans; Karin J Naarding; Erik H Niks; Louise A M Otto; W Ludo van der Pol; Martijn R Tannemaat; Hermien E Kan; Martijn Froeling
Journal:  Magn Reson Med       Date:  2020-04-19       Impact factor: 4.668

6.  Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy.

Authors:  Natasha L Hornby; Randi Drees; Rachel Harron; Ruby Chang; Dominic J Wells; Richard J Piercy
Journal:  Neuromuscul Disord       Date:  2021-06-02       Impact factor: 4.296

7.  Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic.

Authors:  Claudia R Senesac; Alison M Barnard; Donovan J Lott; Kavya S Nair; Ann T Harrington; Rebecca J Willcocks; Kirsten L Zilke; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2020-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.